Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r9data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

Published by 13 Sep 2026

Drag the red line through time · ← → a day · Shift+← → a week. Later days aren’t drawn: they haven’t been published yet.

Scope · likely financings by canton

36 likely financings · 15 Aug 2026 – 13 Sep 2026 · the feed below shows one weekAG ✕ show all cantonsMap: Natural Earth

Likely financing: Looks like new money from outside investors: Claude, reading the entry and the rule signals, scores it 0.60 or higher.
Undecided: Some financing signals, not enough to call it: a score from 0.35 to below 0.60, or no usable score.
Capital increased: No sign of a financing round: the pre-filter found nothing to send to Claude, or Claude scored it below 0.35. Typical causes are converted loans, assets contributed in kind, reserves turned into capital or a conversion to an AG.
Confirmed round: A financing announcement on startupticker.ch names the company and matches this increase.

Published 7–13 Sep 2026 · canton AG

2 capital increases · 1 shown

Capital increases published 7–13 Sep 2026
Company	Status	Nominal share capital (CHF) before → after	New shares, % of post-step shares	Announced roundnot disclosed in the SHAB	SHAB published	Source
ASTRA Therapeutics AGAG · Die Gesellschaft bezweckt die Entdeckung, Entwicklung, Herstellung und Kommerzialisierung von neuen …SHAB publication HR02-1006751126	Likely financingscore 0.86	153’277.22 → 188’300.77New shares 18.6%	18.6%	—	8 Sep 2026	SHAB publication HR02-1006751126

1 other capital increase published this week ▸